StockWatch
·
Orthopedic, Prosthetic & Surgical Appliances & Supplies
New LaunchNov 17, 2026, 08:31 AM

Conexeu Sciences Develops New Wound Care Formats: W.A.F.E.R.™

AI Summary

Conexeu Sciences Inc. announced the development of W.A.F.E.R.™ (WIDE APPLICATION FABRICATED EXTRACELLULAR MATRIX FOR RESTORATION™), two new fabricated formats for its CXU™ collagen-based scaffold platform: W.A.F.E.R.™ Sheet and W.A.F.E.R.™ Lattice. These formats are designed to complement the existing flowable CXU™ device candidate and address different wound geometries. The company continues to target its FDA 510(k) submission for the flowable device in Q1 2027, with the W.A.F.E.R.™ formats in early-stage development and following their own regulatory path.

Key Highlights

  • Conexeu Sciences develops W.A.F.E.R.™ Sheet and W.A.F.E.R.™ Lattice, new fabricated formats for its CXU™ platform.
  • W.A.F.E.R.™ Sheet is a flexible format for broad wound surfaces.
  • W.A.F.E.R.™ Lattice is a 3D scaffold for large volumetric defects.
  • These formats complement the flowable CXU™ device candidate.
  • Company targets FDA 510(k) submission for flowable CXU™ in Q1 2027.
  • W.A.F.E.R.™ formats are in early-stage development and will follow a separate regulatory path.